Dr. Neuman is a long-standing member of the CSCC. As a translational researcher, she has been positioned at the forefront of liver and gastroenterology innovation for nearly forty years. Dr. Neuman has conducted groundbreaking research and written extensively about non-invasive biomarkers in liver disease. She has published more than 80 original papers, 12 book chapters and 230 abstracts, and has presented more than 315 invited lectures. The CSCC notes that “Dr. Neuman’s contributions to science and education in the field of liver disease and toxicology have made a significant difference in the health care of patients in Canada and the world.”
We are also pleased to announce that Dr. Neuman has been named a recipient of the 2021 Lifetime Recognition Award from the European Association for Alcoholism.
Dr. Neuman is a long-standing member of the CSCC. As a translational researcher, she has been positioned at the forefront of liver and gastroenterology innovation for nearly forty years. Dr. Neuman has conducted groundbreaking research and written extensively about non-invasive biomarkers in liver disease. She has published more than 80 original papers, 12 book chapters and 230 abstracts, and has presented more than 315 invited lectures. The CSCC notes that “Dr. Neuman’s contributions to science and education in the field of liver disease and toxicology have made a significant difference in the health care of patients in Canada and the world.”
We are also pleased to announce that Dr. Neuman has been named a recipient of the 2021 Lifetime Recognition Award from the European Association for Alcoholism.